GHRH receptor agonism
Activates the anterior-pituitary GHRH receptor to drive endogenous GH release in physiologic pulses.
Free UAE shipping over AED 750
NuroPens · Metabolic
From AED 299.00
— Build your NuroPen™
Choose how many milligrams you want, the larger the pen the bigger the volume discount.
Want to try a different compound? Open the full NuroPen™ Builder →
This compound is temporarily unavailable. Restock dates vary by lot; leave your email and we will notify you the moment it ships.
— About
Tesa Pre-Filled Pen is a multi-dose injection pen format for Tesa, a GHRH analog for visceral fat reduction. The pen format eliminates manual reconstitution, click-dial dosing simplifies the protocol, and the cartridge keeps the compound stable across the use window.
For research-context use only. See the Tesa Ingredient Library entry for mechanism, dose patterns, and the published research base.
Cold-chain dispatched within 1–3 business days from Abu Dhabi. UAE delivery 1–3 days; GCC 3–5 days; international 7–21 days where lawful. Free UAE delivery on orders over AED 900.
Sealed lyophilized peptide powder under inert atmosphere. No fillers, no flow agents, no excipients beyond the standard lyo cake matrix. Each batch is independently lab-tested for purity (HPLC), identity (mass spec), heavy metals, and microbial load. Batch-matched Certificates of Analysis are available on request to verified buyers, email [email protected] with your order number.
Lyophilized vials are stable at room temperature in the original packaging. Once reconstituted, store refrigerated (2–8°C) and use within the compound's stability window. The Dosage Calculator notes per-compound stability.
— Tools for this compound
— Why this compound
A growth hormone-releasing hormone analog. Studied across visceral adipose tissue research and long-form lipid metabolism work.
— How it works
This compound is a synthetic analog of growth hormone-releasing hormone (GHRH), modified for resistance to enzymatic degradation. It binds the GHRH receptor in the anterior pituitary and stimulates a pulsatile pattern of endogenous growth hormone release.
The pulsatile profile is the mechanism that distinguishes GHRH-analog research from direct GH administration: physiologic release patterns preserve negative feedback, and research has examined the downstream effects of restored pulsatility on the IGF-1 axis, lipid metabolism, and visceral adipose tissue.
The compound is documented across specific lipodystrophy-research populations, where studies have tracked visceral adipose and lipid panel markers over multi-month protocols. Wider research interest has extended into general metabolic and aging-related GH-axis research.
— Research focus
Research-framed mechanisms studied for this compound. Citations below describe published work; they do not represent product claims.
Activates the anterior-pituitary GHRH receptor to drive endogenous GH release in physiologic pulses.
Multi-month studies in specific research populations have measured changes in visceral adipose tissue and trunk fat composition.
Research data report effects on triglyceride and cholesterol fractions consistent with GH-axis stimulation.
Endogenous GH release downstream of GHRH signaling drives hepatic IGF-1 production. Research tracks this axis as a longevity-relevant marker.
— Operational notes
Add bacteriostatic water to the lyophilized vial along the wall, never directly onto the cake. Swirl gently, do not shake. Powder should fully dissolve into a clear solution.
Refrigerate (2–8 °C) immediately after reconstitution. Keep upright in the original packaging away from light. Lyophilized vials stay stable at room temperature in their original sealed packaging.
Use within the compound stability window noted on the COA. Protocols vary by compound, see the Dosage Calculator for per-compound timing and the Ingredient Library entry for research-grade reference ranges.
Reconstituted shelf life is compound-specific. Discard the vial if the solution shows visible cloudiness, particulates, or color change. The Calculator notes per-compound stability windows.

Muscle
Muscle

Recovery
Recovery

Recovery
Recovery

Recovery
Recovery
— Published research
Citations below describe published research on the compound. They do not represent claims about NuroCore products.
Phase 3 visceral adipose tissue outcomes over 26 weeks of administration.
Measures hepatic fat fraction changes in research-protocol populations.
Extended-duration safety + IGF-1 axis tracking in clinical research.
Reviews the rationale for pulsatile GH release vs direct GH administration.
— Frequently asked
Every batch is independently tested for purity, identity, heavy metals, and microbial contamination before it ships. Formulations use clinical-evidence doses, not under-doses dressed up as a "complex". For any specific medical concern, please consult a qualified healthcare professional.
Most UAE orders arrive within 1–3 business days. Cold-chain dispatched, discreet packaging. Cash on Delivery is available across the UAE if you'd rather not share card details online.
Yes, where lawful. GCC countries typically arrive in 3–5 business days; further international destinations in 7–21 days depending on customs. Buyers are responsible for confirming legality of import in their jurisdiction.
Yes. The site uses bank-level encryption end to end. Payments run through Ziina (UAE-licensed) and Tabby (regulated BNPL); we never see card data on our servers. Cash on Delivery is also available across the UAE.
Yes. Outer packaging is unmarked, with no NuroCore branding, no compound names, and no health-product references. Just a plain shipping carton. Your privacy is part of the product.
— Continued reading
Compound Notes · 4 min read
Read →
Compound Notes · 4 min read
Read →
Compound Notes · 4 min read
Read →
— You were just looking at
21+ Verification
These products are not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
For research use only
Added to cart
NuroCore Assistant
Compound info, products, your questions.
Start typing to search the catalogue.
Field Notes
Research notes, protocol releases, and journal essays for those treating their body as an asset. No spam. Unsubscribe anytime.
A note on cookies.
We use cookies for essential site functionality and, with your permission, to measure how you use the site so we can improve it. Read our privacy policy for details.